Medical Aesthetic Devices Market By Product (Devices, Aesthetic Implants), By Application (Surgical, Non Surgical), By End User (Hospitals And Clinics, Medical Spas And Beauty Centers): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global medical aesthetic device market was valued at $13,529.6 million in 2020, and is projected to reach $38,916.6 million by 2030, registering a CAGR of 10.7% from 2021 to 2030.
Medical aesthetic is a medical filed, which is focused on procedures and techniques for improving the appearance, texture, and contours of the face, body, and skin by treating various conditions such as moles, excess fat, skin looseness, cellulite, poker, scars, liver spots, wrinkles, cellulite, and unwanted hair. Furthermore, these technologies (especially implants) correct deformities caused by accidents, trauma, and other congenital conditions. Aesthetic medicine includes both surgical and non-surgical techniques, and a combination of both can be utilized to improve a person's physical appearance.
The major factors that drive the growth of the global medical aesthetic device market include technological advancements, high demand for minimally invasive & non-invasive reconstruction surgeries, rise in incidence of congenital face & tooth deformities, and surge in awareness for aesthetic appearance. However, high costs of treatment, low reimbursements, and risk of malfunctions associated with implants restrict the market growth.
The global medical aesthetic device market is segmented into type of product, application, end user, and region. By product type, the market is divided into devices and aesthetic implants. On the basis of application, it is bifurcated into surgical and non-surgical. Depending on end user, it is segregated into hospitals & clinics and medical spas & beauty centers. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include the Allergan PLC, Solta Medical , Syneron Medical Ltd., Cynosure Inc., Lumenis Ltd. Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Alma Lasers Ltd. (acquired by Shanghai Fosun Pharmaceutical (Group) Co., GC Aesthetics Plc., Sientra Inc., Zimmer Biomet Holdings, Inc., and Dentsply Sirona Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market, with current trends and future estimations to elucidate imminent investment pockets.
It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2021 to 2030 to enable stakeholders to capitalize on prevailing market opportunities.
Analysis based on product type helps understand various types of devices used during a cosmetic procedure.
Key players have been profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
Key Market Segments
By Product
Devices
Aesthetic Implants
By Application
Surgical
Non Surgical
By End User
Hospitals And Clinics
Medical Spas And Beauty Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Colombia
Saudi Arabia
Rest of LAMEA
Key Market Players
Allergan plc
Dentsply Sirona Inc.
Johnson & Johnson
LUMENIS LTD
MERZ PHARMA GMBH & CO. KGAA
Hologic, Inc.
Sientra Inc
SYNERON MEDICAL LTD
VALEANT PHARMACEUTICAL INTERNATIONAL, INC
Zimmer Biomet Holdings, Inc.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Aesthetic Implants
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Surgical
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Non Surgical
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: MEDICAL AESTHETIC DEVICES MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals And Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Medical Spas And Beauty Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- CHAPTER 7: MEDICAL AESTHETIC DEVICES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 United Kingdom
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 South Korea
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 Australia
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Colombia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 Saudi Arabia
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Allergan plc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Dentsply Sirona Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Johnson & Johnson
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 LUMENIS LTD
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 MERZ PHARMA GMBH & CO. KGAA
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Hologic, Inc.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Sientra Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 SYNERON MEDICAL LTD
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 VALEANT PHARMACEUTICAL INTERNATIONAL, INC
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Zimmer Biomet Holdings, Inc.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 2. MEDICAL AESTHETIC DEVICES MARKET REVENUE, FOR DEVICES, BY REGION , 2020-2030,($MILLION)
- TABLE 3. MEDICAL AESTHETIC DEVICES MARKET DEVICES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. MEDICAL AESTHETIC DEVICES MARKET REVENUE, FOR AESTHETIC IMPLANTS, BY REGION , 2020-2030,($MILLION)
- TABLE 5. MEDICAL AESTHETIC DEVICES MARKET AESTHETIC IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 7. MEDICAL AESTHETIC DEVICES MARKET REVENUE, FOR SURGICAL, BY REGION , 2020-2030,($MILLION)
- TABLE 8. MEDICAL AESTHETIC DEVICES MARKET SURGICAL BY COUNTRY, 2020-2030,($MILLION)
- TABLE 9. MEDICAL AESTHETIC DEVICES MARKET REVENUE, FOR NON SURGICAL, BY REGION , 2020-2030,($MILLION)
- TABLE 10. MEDICAL AESTHETIC DEVICES MARKET NON SURGICAL BY COUNTRY, 2020-2030,($MILLION)
- TABLE 11. GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 12. MEDICAL AESTHETIC DEVICES MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
- TABLE 13. MEDICAL AESTHETIC DEVICES MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 14. MEDICAL AESTHETIC DEVICES MARKET REVENUE, FOR MEDICAL SPAS AND BEAUTY CENTERS, BY REGION , 2020-2030,($MILLION)
- TABLE 15. MEDICAL AESTHETIC DEVICES MARKET MEDICAL SPAS AND BEAUTY CENTERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 16. MEDICAL AESTHETIC DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 17. NORTH AMERICA MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 18. NORTH AMERICA MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 19. NORTH AMERICA MEDICAL AESTHETIC DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 20. NORTH AMERICA MEDICAL AESTHETIC DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 21. U.S. MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 22. U.S. MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 23. U.S. MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 24. CANADA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 25. CANADA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 26. CANADA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 27. MEXICO MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 28. MEXICO MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 29. MEXICO MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 30. EUROPE MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 31. EUROPE MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 32. EUROPE MEDICAL AESTHETIC DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 33. EUROPE MEDICAL AESTHETIC DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 34. GERMANY MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 35. GERMANY MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 36. GERMANY MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 37. FRANCE MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 38. FRANCE MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 39. FRANCE MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 40. UNITED KINGDOM MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 41. UNITED KINGDOM MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 42. UNITED KINGDOM MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 43. ITALY MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 44. ITALY MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 45. ITALY MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 46. SPAIN MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 47. SPAIN MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 48. SPAIN MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 49. REST OF EUROPE MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 50. REST OF EUROPE MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 51. REST OF EUROPE MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 52. ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 53. ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 54. ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 55. ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 56. JAPAN MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 57. JAPAN MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 58. JAPAN MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 59. CHINA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 60. CHINA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 61. CHINA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 62. INDIA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 63. INDIA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 64. INDIA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 65. SOUTH KOREA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 66. SOUTH KOREA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 67. SOUTH KOREA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 68. AUSTRALIA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 69. AUSTRALIA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 70. AUSTRALIA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 74. LAMEA MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 75. LAMEA MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 76. LAMEA MEDICAL AESTHETIC DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 77. LAMEA MEDICAL AESTHETIC DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 78. BRAZIL MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 79. BRAZIL MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 80. BRAZIL MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 81. COLOMBIA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 82. COLOMBIA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 83. COLOMBIA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 84. SAUDI ARABIA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 85. SAUDI ARABIA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 86. SAUDI ARABIA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 87. REST OF LAMEA MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 88. REST OF LAMEA MEDICAL AESTHETIC DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 89. REST OF LAMEA MEDICAL AESTHETIC DEVICES MARKET BY END USER 2020-2030,($MILLION)
- TABLE 90.ALLERGAN PLC: COMPANY SNAPSHOT
- TABLE 91.ALLERGAN PLC: OPERATING SEGMENTS
- TABLE 92.ALLERGAN PLC: PRODUCT PORTFOLIO
- TABLE 93.ALLERGAN PLC: NET SALES,
- TABLE 94.ALLERGAN PLC: KEY STRATERGIES
- TABLE 95.DENTSPLY SIRONA INC.: COMPANY SNAPSHOT
- TABLE 96.DENTSPLY SIRONA INC.: OPERATING SEGMENTS
- TABLE 97.DENTSPLY SIRONA INC.: PRODUCT PORTFOLIO
- TABLE 98.DENTSPLY SIRONA INC.: NET SALES,
- TABLE 99.DENTSPLY SIRONA INC.: KEY STRATERGIES
- TABLE 100.JOHNSON & JOHNSON: COMPANY SNAPSHOT
- TABLE 101.JOHNSON & JOHNSON: OPERATING SEGMENTS
- TABLE 102.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
- TABLE 103.JOHNSON & JOHNSON: NET SALES,
- TABLE 104.JOHNSON & JOHNSON: KEY STRATERGIES
- TABLE 105.LUMENIS LTD: COMPANY SNAPSHOT
- TABLE 106.LUMENIS LTD: OPERATING SEGMENTS
- TABLE 107.LUMENIS LTD: PRODUCT PORTFOLIO
- TABLE 108.LUMENIS LTD: NET SALES,
- TABLE 109.LUMENIS LTD: KEY STRATERGIES
- TABLE 110.MERZ PHARMA GMBH & CO. KGAA: COMPANY SNAPSHOT
- TABLE 111.MERZ PHARMA GMBH & CO. KGAA: OPERATING SEGMENTS
- TABLE 112.MERZ PHARMA GMBH & CO. KGAA: PRODUCT PORTFOLIO
- TABLE 113.MERZ PHARMA GMBH & CO. KGAA: NET SALES,
- TABLE 114.MERZ PHARMA GMBH & CO. KGAA: KEY STRATERGIES
- TABLE 115.HOLOGIC, INC.: COMPANY SNAPSHOT
- TABLE 116.HOLOGIC, INC.: OPERATING SEGMENTS
- TABLE 117.HOLOGIC, INC.: PRODUCT PORTFOLIO
- TABLE 118.HOLOGIC, INC.: NET SALES,
- TABLE 119.HOLOGIC, INC.: KEY STRATERGIES
- TABLE 120.SIENTRA INC: COMPANY SNAPSHOT
- TABLE 121.SIENTRA INC: OPERATING SEGMENTS
- TABLE 122.SIENTRA INC: PRODUCT PORTFOLIO
- TABLE 123.SIENTRA INC: NET SALES,
- TABLE 124.SIENTRA INC: KEY STRATERGIES
- TABLE 125.SYNERON MEDICAL LTD: COMPANY SNAPSHOT
- TABLE 126.SYNERON MEDICAL LTD: OPERATING SEGMENTS
- TABLE 127.SYNERON MEDICAL LTD: PRODUCT PORTFOLIO
- TABLE 128.SYNERON MEDICAL LTD: NET SALES,
- TABLE 129.SYNERON MEDICAL LTD: KEY STRATERGIES
- TABLE 130.VALEANT PHARMACEUTICAL INTERNATIONAL, INC: COMPANY SNAPSHOT
- TABLE 131.VALEANT PHARMACEUTICAL INTERNATIONAL, INC: OPERATING SEGMENTS
- TABLE 132.VALEANT PHARMACEUTICAL INTERNATIONAL, INC: PRODUCT PORTFOLIO
- TABLE 133.VALEANT PHARMACEUTICAL INTERNATIONAL, INC: NET SALES,
- TABLE 134.VALEANT PHARMACEUTICAL INTERNATIONAL, INC: KEY STRATERGIES
- TABLE 135.ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
- TABLE 136.ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
- TABLE 137.ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
- TABLE 138.ZIMMER BIOMET HOLDINGS, INC.: NET SALES,
- TABLE 139.ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.MEDICAL AESTHETIC DEVICES MARKET SEGMENTATION
- FIGURE 2.MEDICAL AESTHETIC DEVICES MARKET,2020-2030
- FIGURE 3.MEDICAL AESTHETIC DEVICES MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.MEDICAL AESTHETIC DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.MEDICAL AESTHETIC DEVICES MARKET,BY PRODUCT,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DEVICES MEDICAL AESTHETIC DEVICES MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF AESTHETIC IMPLANTS MEDICAL AESTHETIC DEVICES MARKET,2020-2030(%)
- FIGURE 14.MEDICAL AESTHETIC DEVICES MARKET,BY APPLICATION,2020(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SURGICAL MEDICAL AESTHETIC DEVICES MARKET,2020-2030(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF NON SURGICAL MEDICAL AESTHETIC DEVICES MARKET,2020-2030(%)
- FIGURE 17.MEDICAL AESTHETIC DEVICES MARKET,BY END USER,2020(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS MEDICAL AESTHETIC DEVICES MARKET,2020-2030(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MEDICAL SPAS AND BEAUTY CENTERS MEDICAL AESTHETIC DEVICES MARKET,2020-2030(%)
- FIGURE 20.MEDICAL AESTHETIC DEVICES MARKET BY REGION,2020
- FIGURE 21.U.S. MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 22.CANADA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 23.MEXICO MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 24.GERMANY MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 25.FRANCE MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 26.UNITED KINGDOM MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 27.ITALY MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 28.SPAIN MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 29.REST OF EUROPE MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 30.JAPAN MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 31.CHINA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 32.INDIA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 33.SOUTH KOREA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 34.AUSTRALIA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 35.REST OF ASIA-PACIFIC MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 36.BRAZIL MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 37.COLOMBIA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 38.SAUDI ARABIA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 39.REST OF LAMEA MEDICAL AESTHETIC DEVICES MARKET,2020-2030($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44.COMPETITIVE DASHBOARD
- FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 46.ALLERGAN PLC.: NET SALES ,($MILLION)
- FIGURE 47.DENTSPLY SIRONA INC..: NET SALES ,($MILLION)
- FIGURE 48.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
- FIGURE 49.LUMENIS LTD.: NET SALES ,($MILLION)
- FIGURE 50.MERZ PHARMA GMBH & CO. KGAA.: NET SALES ,($MILLION)
- FIGURE 51.HOLOGIC, INC..: NET SALES ,($MILLION)
- FIGURE 52.SIENTRA INC.: NET SALES ,($MILLION)
- FIGURE 53.SYNERON MEDICAL LTD.: NET SALES ,($MILLION)
- FIGURE 54.VALEANT PHARMACEUTICAL INTERNATIONAL, INC.: NET SALES ,($MILLION)
- FIGURE 55.ZIMMER BIOMET HOLDINGS, INC..: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook